Related Experiment Video
Updated: Jan 23, 2026

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Neurodevelopmental Outcomes Comparing Bevacizumab to Laser for Type 1 ROP
Insights
Intravitreal bevacizumab (IVB) treatment for retinopathy of prematurity (ROP) showed no significant differences in major neurodevelopmental outcomes compared to laser therapy. However, IVB may offer protection against vision loss.
Area of Science:
- Ophthalmology
- Neurodevelopmental Pediatrics
- Neonatal Care
Background:
- Retinopathy of prematurity (ROP) is a significant cause of visual impairment in premature infants.
- Treatment modalities for ROP include laser photocoagulation and intravitreal bevacizumab (IVB).
- Evaluating long-term neurodevelopmental outcomes is crucial for assessing the impact of ROP treatments.
Purpose of the Study:
- To compare neurodevelopmental outcomes in infants treated for ROP with laser versus primary intravitreal bevacizumab (IVB).
- To identify factors associated with cerebral palsy (CP) in infants treated for ROP.
- To assess the impact of ROP treatment on visual impairment and cognitive development.
Main Methods:
- Retrospective chart review of infants treated for ROP.
- Comparison of primary outcomes: death, hearing loss, bilateral visual impairment (BVI), and cerebral palsy (CP).
- Calculation of odds ratios (ORs) for CP and analysis of Bayley Scales of Infant and Toddler Development, Third Edition (BSID-III) scores.
Main Results:
- No significant differences in overall primary outcomes between laser and IVB treatment groups.
- Adjusted odds of BVI were significantly higher with laser treatment compared to IVB (OR = 13.1; P = .038).
- Hydrocephalus and BVI were strongly correlated with CP; IVB was not associated with CP.
Conclusions:
- Intravitreal bevacizumab (IVB) treatment for ROP was not associated with severe developmental disabilities.
- IVB may provide a protective effect against vision loss in infants treated for ROP.
- Visual outcomes are integral to neurodevelopmental assessment in ROP patients.
Background And Objective:
To evaluate neurodevelopmental outcomes among infants treated for retinopathy of prematurity (ROP) at the authors' institution.
Patients And Methods:
Before-and-after retrospective chart reviews identified 40 infants treated with laser and 46 treated with primary intravitreal bevacizumab (IVB). Primary outcomes were death, hearing loss, bilateral visual impairment (BVI), and cerebral palsy (CP); odds ratios (ORs) were calculated to determine factors associated with CP. Secondary outcomes were mean Bayley Scales of Infant and Toddler Development, Third Edition (BSID-III) scores.
Results:
Overall, there were no significant differences in primary outcome measures by treatment group. However, adjusted odds of BVI were significantly higher with laser compared to IVB (OR = 13.1; P = .038). Although IVB was not associated with CP, both hydrocephalus and BVI were strongly correlated with CP. Mean Bayley-III scores were similar when comparing nine laser-treated infants to 13 IVB-treated infants.
Conclusions:
Visual outcomes are an important aspect of neurodevelopment. IVB was not associated with severe developmental disabilities and may protect against vision loss in this analysis. [Ophthalmic Surg Lasers Imaging Retina. 2019;50:337-343.].
Related Concept Videos
Predicting Reaction Outcomes
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Comparing the Survival Analysis of Two or More Groups
Comparing Experimental Results: Student's t-Test

